|
|
Effects of Continuous Renal Replacement Therapy Combined with Hemadsorption on Renal Function and Levels of Serum TLR4 and CTnI in Treating Septic Shock |
LI Yan |
The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830000, China |
|
|
Abstract Objective: To observe the effects of continuous renal replacement therapy (CRRT) combined with hemadsorption on renal function and levels of serum Toll-like receptor 4 (TLR4) and cardiac troponin I (cTnI) in the treatment of septic shock. Methods: A total of 139 patients with septic shock treated in the hospital between October 2018 and October 2020 were selected as the research subjects, and they were divided into control group (69 cases) and observation group (70 cases) according to the stratified randomization of the random number table method. The control group was given conventional treatment, and the observation group was given CRRT combined with hemadsorption on the basis of conventional treatment. The perioperative basic status (shock duration, ambulation time, hospital stay) were compared between the two groups, and the renal function [serum cystatin C (cysC), neutrophil gelatinase-associated lipocalin (NGAL)], immune function [TLR4, nuclear factor-κB (NF-κB)] and myocardial function [cTnI, creatine kinase isoenzyme MB (CK-MB)] of the two groups of patients were compared before treatment and 1 week after treatment. Results: The shock duration, ambulation time and hospital stay in observation group were significantly shorter than those in control group (P<0.05). 1 week after treatment, the levels of cysC, NGAL, TLR4, NF-κB, cTnI and CK-MB in the two groups were significantly decreased compared with those before treatment (P<0.05), and the decrease ranges of cysC, NGAL and NF-κB in observation group were significantly higher than those in the control group (P<0.05). Conclusion: CRRT combined with hemadsorption has a significant efficacy on patients with septic shock, and it can effectively improve the renal function, remove the inflammatory mediators, and reduce the levels of serum TLR4 and cTnI, with high clinical application value.
|
|
|
|
|
[1] 胡清甫,张尤帅,林莹雪,等.不同连续性肾脏替代治疗模式对脓毒症急性肾损伤患者溶质清除效果的比较[J].中国临床研究,2019,32(2):236~238,243. [2] 杜晓敏,翟磊.不同肾脏替代治疗模式对脓毒症休克合并多脏器功能损害患者的疗效观察[J].中国医药导刊,2018,20(10):598~601. [3] 米芷颉,龚鸿昌,俸小飞.连续肾脏替代疗法对感染性休克致急性肾损伤患者的临床意义[J].标记免疫分析与临床,2018,25(7):1048~1051,1056. [4] 宋小青,李鹏.连续性肾脏替代治疗对难治性心力衰竭患者心肝肾功能、血清FGF-23、TnT水平的影响[J].海南医学,2020,31(8):972~975. [5] 丁国雷,练睿,袁烁.连续性肾脏替代治疗时机对脓毒性休克伴急性肾损伤患者预后的影响[J].中日友好医院学报,2019,33(6):346~348. [6] 曹钰,柴艳芬,邓颖,等.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].临床急诊杂志,2018,19(9):567~588. [7] 杨秀红,胡述立,范学朋.血必净注射液对脓毒性休克患者心功能的保护作用及机制探讨[J].辽宁中医杂志,2019,46(4):752~755. [8] 朱玉菡,沈晓旭,江其敏,等.脉搏指示连续心排血量监测指导脓毒性休克患者治疗效果的Meta分析[J].中国循证医学杂志,2017,17(8):934~940. [9] 詹文丽,苏显都.血清降钙素原和C反应蛋白在脓毒性休克患者中的变化及对预后的评估[J].中国感染控制杂志,2017,16(2):160~165. [10] 张颖,袁杉,汪阳.脓毒性休克患者血清C-反应蛋白、降钙素原和NT-pro-BNP水平及预后意义[J].空军医学杂志,2018,34(1):52~56. [11] 闵玉娣,权明桃,陈妮,等.脓毒性休克患者发生急性肾损伤危险因素的Meta分析[J].河北医学,2020,26(3):463~468. |
|
|
|